Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021

We describe the development of a risk assessment profile tool that incorporates data from multiple domains to help determine activities and events where rapid antigen detection tests (Ag-RDT) could be used to screen asymptomatic individuals to identify infectious cases as an additional mitigation me...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallon, Patrick WG, Horgan, Mary, McAloon, Conor G, Lunn, Peter D, Little, Julian, Beck, Andrew, Bennett, Alexandria, Shaver, Nicole, McConway, Aileen, O’Regan, Rhea, Whelan, Barbara, Connell, Jeff, Lunn, Pete, Mallon, Patrick, Mills, Kingston HG, O’Mahony, Patrick, Prior, Anna-Rose, Smyth, Breda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804664/
https://www.ncbi.nlm.nih.gov/pubmed/35057900
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.3.2101202
Descripción
Sumario:We describe the development of a risk assessment profile tool that incorporates data from multiple domains to help determine activities and events where rapid antigen detection tests (Ag-RDT) could be used to screen asymptomatic individuals to identify infectious cases as an additional mitigation measure to reduce transmission of SARS-CoV-2. The tool aims to stratify, in real time, the overall risk of SARS-CoV-2 transmission associated with common activities and events, and this can be matched to an appropriate Ag-RDT testing protocol.

Ejemplares similares